Mai Capital Management Skye Bioscience, Inc. Put Options Transaction History
Mai Capital Management
- $10.1 Billion
- Q3 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
About Skye Bioscience, Inc.
- Ticker SKYE
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 495,924,992
- Market Cap $2.18B
- Description
- Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical t...